Similar articles

• [Multidrug resistance in acute nonlymphoid leukemia].

  Michieli M, Geromin A, Damiani D, Michelutti A, Raspadori D, Masotti A, Russo D, Fanin R, Fasola G, Mallardi F, et al. Michieli M, et al. Haematologica. 1991 Jun;76 Suppl 3:165-8. Haematologica. 1991. PMID: 1684342 Italian. No abstract available.
• [Glycoprotein P-170, associated with multidrug resistance, in patients with acute leukemia in complete remission].

  Musto P, Carotenuto M. Musto P, et al. Haematologica. 1991 Jun;76 Suppl 3:169-72. Haematologica. 1991. PMID: 1684343 Italian. No abstract available.
• [Multidrug resistance in lymphoproliferative syndromes].

  Damiani D, Michelutti A, Michieli M, Geromin A, Raspadori D, Giacca M, Mallardi F, Baccarani M. Damiani D, et al. Haematologica. 1991 Jun;76 Suppl 3:162-4. Haematologica. 1991. PMID: 1684341 Italian. No abstract available.
• Multidrug resistance: clinical relevance in acute leukemia.

  List AF. List AF. Oncology (Williston Park). 1993 Oct;7(10):23-8, 32; discussion 32, 35-8. Oncology (Williston Park). 1993. PMID: 7902728 Review.
• Multidrug resistance.

  Moscow JA, Cowan KH. Moscow JA, et al. Cancer Chemother Biol Response Modif. 1991;12:91-109. Cancer Chemother Biol Response Modif. 1991. PMID: 1681846 Review. No abstract available.